Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility
Abstract The value of in silico methods in drug development and evaluation has been demonstrated repeatedly and convincingly. While their benefits are now unanimously recognized, international standards for their evaluation, accepted by all stakeholders involved, are still to be established. In this...
Enregistré dans:
Auteurs principaux: | Flora T. Musuamba, Ine Skottheim Rusten, Raphaëlle Lesage, Giulia Russo, Roberta Bursi, Luca Emili, Gaby Wangorsch, Efthymios Manolis, Kristin E. Karlsson, Alexander Kulesza, Eulalie Courcelles, Jean‐Pierre Boissel, Cécile F. Rousseau, Emmanuelle M. Voisin, Rossana Alessandrello, Nuno Curado, Enrico Dall’ara, Blanca Rodriguez, Francesco Pappalardo, Liesbet Geris |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/97e2e67f5a5b4314bf9e9f73a5497dde |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Scientific and regulatory evaluation of empirical pharmacometric models: An application of the risk informed credibility assessment framework
par: Ine Skottheim Rusten, et autres
Publié: (2021) -
Empirical evidence on the relation between fiscal credibility and Central Bank credibility: the Brazilian case
par: Gabriel Caldas Montes, et autres
Publié: (2019) -
Credibility and inflation targeting in Chile
par: Céspedes, Luis Felipe, et autres
Publié: (2019) -
Independence, credibility, and communication of central banking
Publié: (2021) -
Reputation, credibility and monetary policy effectiveness
par: Gabriel Caldas Montes
Publié: (2009)